The gut microbiome is a complex ecosystem in the gastrointestinal tract composed of trillions of bacteria, viruses, fungi, and protozoa. Disruption of this delicate ecosystem, formally called “dysbiosis”, has been linked to a variety of metabolic and inflammatory pathologies. Several studies have focused on abnormal microbiome composition and correlated these findings with the development of type 2 diabetes mellitus (T2DM) and diabetic retinopathy (DR). However, given the complexity of this ecosystem, the current studies are narrow in design and present variable findings. Composition of the gut microbiome in patients with DR significantly differs from patients with diabetes without retinopathy as well as from healthy controls. Additionally, the gut microbiome has been shown to modify effects of medication, diet, exercise, and antioxidant use on the development and progression of DR. In this paper, we present a comprehensive review of literature on the effect of oxidative stress, antioxidant therapies, and dysbiosis on DR.
AnupamKKaushalJPrabhakarN, et al.Effect of redox status of peripheral blood on immune signature of circulating regulatory and cytotoxic T cells in streptozotocin induced rodent model of type I diabetes. Immunobiology2018; 223: 586–597. DOI: https://doi.org/10.1016/j.imbio.2018.07.004.
3.
TatschEDe CarvalhoJAHausenBS, et al.Oxidative DNA damage is associated with inflammatory response, insulin resistance and microvascular complications in type 2 diabetes. Mutat Res2015; 782: 17–22. DOI: https://doi.org/10.1016/j.mrfmmm.2015.10.003.
4.
GeraldesPHiraoka-YamamotoJMatsumotoM, et al.Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med2009; 15: 1298–1306. DOI: https://doi.org/10.1038/nm.2052.
5.
LiQParkKLiC, et al.Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-beta isoform in the endothelium. Circ Res2013; 113: 418–427. DOI: https://doi.org/10.1161/CIRCRESAHA.113.301074.
6.
YuanTYangTChenH, et al.New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol2019; 20: 247–260. DOI: https://doi.org/10.1016/j.redox.2018.09.025.
LeulescuC. [The pathogenesis of cotton-wool spots]. Oftalmologia1997; 41: 296–299.
14.
ShakeriHLemmensKGevaertAB, et al.Cellular senescence links aging and diabetes in cardiovascular disease. Am J Physiol-Heart Circul Physiol2018; 315: H448–H462. DOI: https://doi.org/10.1152/ajpheart.00287.2018.
15.
MehnertH. Diabetes mellitus as a clinical model of the process of aging. Eur J Med Res1997; 2: 441–444.
16.
ResnickHEHarrisMIBrockDB, et al.American Diabetes association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the third national health and nutrition examination survey. Diabetes Care2000; 23: 176–180. DOI: https://doi.org/10.2337/diacare.23.2.176.
17.
MonickarajFAravindSGokulakrishnanK, et al.Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem2012; 365: 343–350. DOI: https://doi.org/10.1007/s11010-012-1276-0.
RoySTonkissJRoyS. Aging increases retinal vascular lesions characteristic of early diabetic retinopathy. Biogerontology2010; 11: 447–455. DOI: https://doi.org/10.1007/s10522-010-9263-x.
20.
MohamedMEIEl-ShaarawyEAAYouakimMF, et al.Aging changes in the retina of male albino rat: a histological, ultrastructural and immunohistochemical study. Folia Morphol (Warsz)2019; 78: 237–258. DOI: https://doi.org/10.5603/FM.a2018.0075.
MaWWongWT. Aging changes in retinal microglia and their relevance to age-related retinal disease. Adv Exp Med Biol2016; 854: 73–78. DOI: https://doi.org/10.1007/978-3-319-17121-0_11.
Luevano-ContrerasCChapman-NovakofskiK. Dietary advanced glycation end products and aging. Nutrients2010; 2: 1247–1265. DOI: https://doi.org/10.3390/nu2121247.
25.
UribarriJWoodruffSGoodmanS, et al.Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc2010; 110: 911–916.e912. DOI: https://doi.org/10.1016/j.jada.2010.03.018.
HammesHPBrownleeMEdelsteinD, et al.Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia1994; 37: 32–35. DOI: https://doi.org/10.1007/BF00428774.
28.
Diabetic retinopathy study. Report number 6. Design, methods, and baseline results. Report number 7. A modification of the airlie house classification of diabetic retinopathy. Prepared by the diabetic retinopathy. Invest Ophthalmol Vis Sci1981; 21: 1–226.
BrestoffJRArtisD. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol2013; 14: 676–684. DOI: https://doi.org/10.1038/ni.2640.
33.
DasTJayasudhaRChakravarthyS, et al.Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy. Sci Rep2021; 11: 2738. DOI: https://doi.org/10.1038/s41598-021-82538-0.
34.
ArumugamMRaesJPelletierE, et al.Enterotypes of the human gut microbiome. Nature2011; 473: 174–180. DOI: https://doi.org/10.1038/nature09944.
35.
SalgueroMVAl-ObaideMAISinghR, et al.Dysbiosis of gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease. Exp Ther Med2019; 18: 3461–3469. DOI: https://doi.org/10.3892/etm.2019.7943.
36.
RinninellaERaoulPCintoniM, et al.What is the healthy gut microbiota composition? a changing ecosystem across age, environment, diet, and diseases. Microorganisms2019; 7: 1–22. DOI: https://doi.org/10.3390/microorganisms7010014
37.
WuJWangKWangX, et al.The role of the gut microbiome and its metabolites in metabolic diseases. Protein Cell2021; 12: 360–373. DOI: https://doi.org/10.1007/s13238-020-00814-7.
38.
HouttuVBoulundUGrefhorstA, et al.The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. Therap Adv Gastroenterol2020; 13: 1756284820941745. DOI: https://doi.org/10.1177/1756284820941745.
39.
CaniPDAmarJIglesiasMA, et al.Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes2007; 56: 1761–1772. DOI: https://doi.org/10.2337/db06-1491.
40.
GanesanKChungSKVanamalaJ, et al.Causal relationship between diet-induced gut microbiota changes and diabetes: a novel strategy to transplant faecalibacterium prausnitzii in preventing diabetes. Int J Mol Sci2018; 19: 1–28. DOI: https://doi.org/10.3390/ijms19123720
DaoDXieBNadeemU, et al.High-fat diet alters the retinal transcriptome in the absence of gut microbiota. Cells2021; 10: 1–19. DOI: https://doi.org/10.3390/cells10082119
43.
IatcuCOSteenACovasaM. Gut microbiota and complications of type-2 diabetes. Nutrients2021; 14: 1–30. DOI: https://doi.org/10.3390/nu14010166
FernandesRVianaSDNunesS, et al.Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy. Biochim Biophys Acta Mol Basis Dis2019; 1865: 1876–1897. DOI: https://doi.org/10.1016/j.bbadis.2018.09.032.
LarsenNVogensenFKvan den BergFW, et al.Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One2010; 5: e9085. DOI: https://doi.org/10.1371/journal.pone.0009085.
48.
PandolfiCPellegriniLSbalzariniG, et al. [Obesity and insulin resistance]. Minerva Med1994; 85: 167–171.
49.
MuellerNTDifferdingMKZhangM, et al.Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial. Diabetes Care2021; 44: 1462–1471. DOI: https://doi.org/10.2337/dc20-2257.
50.
LeTKHosakaTLeTT, et al.Oral administration of Bifidobacterium spp. Improves insulin resistance, induces adiponectin, and prevents inflammatory adipokine expressions. Biomed Res2014; 35: 303–310. DOI: https://doi.org/10.2220/biomedres.35.303.
51.
de GrootPScheithauerTBakkerGJ, et al.Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time. Gut2020; 69: 502–512. DOI: https://doi.org/10.1136/gutjnl-2019-318320.
52.
VagajaNNBinzNMcLenachanS, et al.Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice. Br J Ophthalmol2013; 97: 1343–1350. DOI: https://doi.org/10.1136/bjophthalmol-2013-303201.
53.
ThakurPSAggarwalDTakkarB, et al.Evidence suggesting the role of gut dysbiosis in diabetic retinopathy. Invest Ophthalmol Vis Sci2022; 63: 21. DOI: https://doi.org/10.1167/iovs.63.8.21.
NewgardCBAnJBainJR, et al.A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab2009; 9: 311–326. DOI: https://doi.org/10.1016/j.cmet.2009.02.002.
56.
PedersenHKGudmundsdottirVNielsenHB, et al.Human gut microbes impact host serum metabolome and insulin sensitivity. Nature2016; 535: 376–381. DOI: https://doi.org/10.1038/nature18646.
57.
El KaoutariAArmougomFGordonJI, et al.The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat Rev Microbiol2013; 11: 497–504. DOI: https://doi.org/10.1038/nrmicro3050.
58.
HeskethGGDennisJW. N-acetylglucosamine: more than a silent partner in insulin resistance. Glycobiology2017; 27: 595–598. DOI: https://doi.org/10.1093/glycob/cwx035.
59.
RyczkoMCPawlingJChenR, et al.Metabolic reprogramming by hexosamine biosynthetic and Golgi N-glycan branching pathways. Sci Rep2016; 6: 23043. DOI: https://doi.org/10.1038/srep23043.
NadeemUBoachie-MensahMZhangJ, et al.Gut microbiome and retinal diseases: an updated review. Curr Opin Ophthalmol2022; 33: 195–201. DOI: https://doi.org/10.1097/ICU.0000000000000836.
64.
TanaseDMGosavEMNeculaeE, et al.Role of gut microbiota on onset and progression of microvascular complications of type 2 diabetes (T2DM). Nutrients2020; 12: 1–26. DOI: https://doi.org/10.3390/nu12123719
65.
MoubayedNMBhatRSAl FarrajD, et al. Screening and identification of gut anaerobes (Bacteroidetes) from human diabetic stool samples with and without retinopathy in comparison to control subjects. Microb Pathog2019; 129: 88–92. DOI: https://doi.org/10.1016/j.micpath.2019.01.025.
66.
KhanRSharmaARavikumarR, et al.Association between gut microbial abundance and sight-threatening diabetic retinopathy. Invest Ophthalmol Vis Sci2021; 62: 19. DOI: https://doi.org/10.1167/iovs.62.7.19.
67.
HuangYWangZMaH, et al.Dysbiosis and implication of the gut microbiota in diabetic retinopathy. Front Cell Infect Microbiol2021; 11: 646348. DOI: https://doi.org/10.3389/fcimb.2021.646348.
68.
JayasudhaRDasTKalyana ChakravarthyS, et al.Gut mycobiomes are altered in people with type 2 diabetes mellitus and diabetic retinopathy. PLoS One2020; 15: e0243077. DOI: https://doi.org/10.1371/journal.pone.0243077.
69.
YePZhangXXuY, et al.Alterations of the gut microbiome and metabolome in patients with proliferative diabetic retinopathy. Front Microbiol2021; 12: 667632. DOI: https://doi.org/10.3389/fmicb.2021.667632.
70.
WangJLiWWangC, et al.Enterotype bacteroides is associated with a high risk in patients with diabetes: a pilot study. J Diabetes Res2020; 2020: 6047145. DOI: https://doi.org/10.1155/2020/6047145.
DuanYPrasadRFengD, et al.Bone marrow-derived cells restore functional integrity of the gut epithelial and vascular barriers in a model of diabetes and ACE2 deficiency. Circ Res2019; 125: 969–988. DOI: https://doi.org/10.1161/CIRCRESAHA.119.315743.
73.
HernándezCOrtegaFGarcía-RamírezM, et al.Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy. Retina2010; 30: 345–352. DOI: https://doi.org/10.1097/iae.0b013e3181b7738b.
74.
HowesELJr.HoffmanMAUlevitchRJ, et al.Ocular localization of circulating bacterial lipopolysaccharide. Exp Eye Res1984; 38: 379–389. DOI: https://doi.org/10.1016/0014-4835(84)90193-3.
75.
AltmannCSchmidtMHH. The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci2018; 19: 1–31. DOI: https://doi.org/10.3390/ijms19010110
76.
YangLPSunHLWuLM, et al.Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Invest Ophthalmol Vis Sci2009; 50: 2319–2327. DOI: https://doi.org/10.1167/iovs.08-2642.
77.
ScholzRSobotkaMCaramoyA, et al.Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration. J Neuroinflammation2015; 12: 209. DOI: https://doi.org/10.1186/s12974-015-0431-4.
78.
DingXGuRZhangM, et al.Microglia enhanced the angiogenesis, migration and proliferation of co-cultured RMECs. BMC Ophthalmol2018; 18: 249. DOI: https://doi.org/10.1186/s12886-018-0886-z.
79.
LeungKWBarnstableCJTombran-TinkJ. Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling. Mol Immunol2009; 46: 1374–1386. DOI: https://doi.org/10.1016/j.molimm.2008.12.001.
80.
MandaliyaDKSeshadriS. Short chain fatty acids, pancreatic dysfunction and type 2 diabetes. Pancreatology2019; 19: 280–284. DOI: https://doi.org/10.1016/j.pan.2019.01.021.
ZhuangRGeXHanL, et al.Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: a systematic review and dose-response meta-analysis. Obes Rev2019; 20: 883–894. DOI: https://doi.org/10.1111/obr.12843.
83.
LiuWWangCXiaY, et al.Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy. Acta Diabetol2021; 58: 221–229. DOI: https://doi.org/10.1007/s00592-020-01610-9.
84.
WahlströmASayinSIMarschallHU, et al.Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab2016; 24: 41–50. DOI: https://doi.org/10.1016/j.cmet.2016.05.005.
85.
de MelloVDPaananenJLindstromJ, et al.Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish diabetes prevention study. Sci Rep2017; 7: 46337. DOI: https://doi.org/10.1038/srep46337.
86.
LaydenBTAngueiraARBrodskyM, et al.Short chain fatty acids and their receptors: new metabolic targets. Transl Res2013; 161: 131–140. DOI: https://doi.org/10.1016/j.trsl.2012.10.007.
87.
CanforaEEJockenJWBlaakEE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol2015; 11: 577–591. DOI: https://doi.org/10.1038/nrendo.2015.128.
VillaSRPriyadarshiniMFullerMH, et al.Loss of free fatty acid receptor 2 leads to impaired islet mass and beta cell survival. Sci Rep2016; 6: 28159. DOI: https://doi.org/10.1038/srep28159.
90.
LiQChangYZhangK, et al.Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Sci Rep2020; 10: 5450. DOI: https://doi.org/10.1038/s41598-020-62224-3.
91.
FernandesJSuWRahat-RozenbloomS, et al.Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes2014; 4: e121. DOI: https://doi.org/10.1038/nutd.2014.23.
92.
BeliEYanYMoldovanL, et al.Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice. Diabetes2018; 67: 1867–1879. DOI: https://doi.org/10.2337/db18-0158.
93.
ChoJGLeeJHHongSH, et al.Tauroursodeoxycholic acid, a bile acid, promotes blood vessel repair by recruiting vasculogenic progenitor cells. Stem Cells2015; 33: 792–805. DOI: https://doi.org/10.1002/stem.1901.
94.
Diaz-LopezABabioNMartinez-GonzalezMA, et al.Erratum. Mediterranean diet, retinopathy, nephropathy, and microvascular diabetes complications: a post hoc analysis of a randomized trial. Diabetes care 2015;38:2134-2141. Diabetes Care2018; 41: 2260–2261. DOI: https://doi.org/10.2337/dc18-er10a.
95.
GhaemiFFirouzabadiFDMoosaieF, et al.Effects of a Mediterranean diet on the development of diabetic complications: a longitudinal study from the nationwide diabetes report of the national program for prevention and control of diabetes (NPPCD 2016-2020). Maturitas2021; 153: 61–67. DOI: https://doi.org/10.1016/j.maturitas.2021.08.003.
96.
WangDDQiQWangZ, et al.The gut microbiome modifies the association between a Mediterranean diet and diabetes in USA hispanic/ latino population. J Clin Endocrinol Metab2022; 107: e924–e934. DOI: https://doi.org/10.1210/clinem/dgab815.
97.
HammerSSGrantMBBusikJV. Intermittent fasting prevents cholesterol accumulation, cholesterol crystal formation and the development of diabetic retinopathy. Invest Ophthalmol Visual Sci2022; 63: 782 – F0341–0782 – F0341.
98.
ChenYGuoTL. Dietary advanced glycation end-products elicit toxicological effects by disrupting gut microbiome and immune homeostasis. J Immunotoxicol2021; 18: 93–104. DOI: https://doi.org/10.1080/1547691X.2021.1959677.
99.
LoubinouxJBronowickiJPPereiraIA, et al.Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol2002; 40: 107–112. DOI: https://doi.org/10.1111/j.1574-6941.2002.tb00942.x.
100.
FigliuoloVRDos SantosLMAbaloA, et al.Sulfate-reducing bacteria stimulate gut immune responses and contribute to inflammation in experimental colitis. Life Sci2017; 189: 29–38. DOI: https://doi.org/10.1016/j.lfs.2017.09.014.
101.
QuWNieCZhaoJ, et al.Microbiome-metabolomics analysis of the impacts of long-term dietary advanced-glycation-end-product consumption on C57BL/6 mouse fecal microbiota and metabolites. J Agric Food Chem2018; 66: 8864–8875. DOI: https://doi.org/10.1021/acs.jafc.8b01466.
102.
SnelsonMCoughlanMT. Dietary advanced glycation end products: digestion, metabolism and modulation of gut microbial ecology. Nutrients2019; 11: 1–15. DOI: https://doi.org/10.3390/nu11020215
103.
ShenJZhangLWangY, et al.Beneficial actions of essential fatty acids in streptozotocin-induced type 1 diabetes mellitus. Front Nutr2022; 9: 890277. DOI: https://doi.org/10.3389/fnut.2022.890277.
104.
OuyangHMeiXZhangT, et al.Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier. Eur J Pharmacol2018; 840: 20–27. DOI: https://doi.org/10.1016/j.ejphar.2018.09.027.
105.
LiuYWangYNiY, et al.Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention. Cell Metab2020; 31: 77–91 e75. DOI: https://doi.org/10.1016/j.cmet.2019.11.001.
106.
TorquatiLGajanandTCoxER, et al.Effects of exercise intensity on gut microbiome composition and function in people with type 2 diabetes. Eur J Sport Sci2023; 23: 530. DOI: https://doi.org/10.1080/17461391.2022.2035436
107.
LiYRyuCMunieM, et al.Association of metformin treatment with reduced severity of diabetic retinopathy in type 2 diabetic patients. J Diabetes Res2018; 2018: 2801450. DOI: https://doi.org/10.1155/2018/2801450.
108.
AminSVKhannaSParvarSP, et al.Metformin and retinal diseases in preclinical and clinical studies: insights and review of literature. Exp Biol Med (Maywood)2022; 247: 317–329. DOI: https://doi.org/10.1177/15353702211069986.
109.
AlomarSYBMBEldosokyM, et al.Protective effect of metformin on rat diabetic retinopathy involves suppression of toll-like receptor 4/nuclear factor-k B expression and glutamate excitotoxicity. Int Immunopharmacol2021; 90: 107193. DOI: https://doi.org/10.1016/j.intimp.2020.107193.
110.
ZhangYChenFWangL. Metformin inhibits development of diabetic retinopathy through microRNA-497a-5p. Am J Transl Res2017; 9: 5558–5566.
111.
YiQYDengGChenN, et al.Metformin inhibits development of diabetic retinopathy through inducing alternative splicing of VEGF-A. Am J Transl Res2016; 8: 3947–3954.
112.
JiaoJYuHYaoL, et al.Recent insights into the role of gut microbiota in diabetic retinopathy. J Inflamm Res2021; 14: 6929–6938. DOI: https://doi.org/10.2147/jir.S336148.
113.
Alarcon YempenREVenzelRPaulino CamposMC, et al.Gut microbiota: a potential therapeutic target for management of diabetic retinopathy?Life Sci2021; 286: 120060. DOI: https://doi.org/10.1016/j.lfs.2021.120060.
114.
WuHEsteveETremaroliV, et al.Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med2017; 23: 850–858. DOI: https://doi.org/10.1038/nm.4345.
115.
ManiarKMoideenAMittalA, et al.A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: genesis of a wonder drug?Pharmacol Res2017; 117: 103–128. DOI: https://doi.org/10.1016/j.phrs.2016.12.003.
MiwaKNakamuraJHamadaY, et al.The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract2003; 60: 1–9. DOI: https://doi.org/10.1016/s0168-8227(02)00248-6.
119.
InoguchiTSontaTTsubouchiH, et al.Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol2003; 14: S227–S232. DOI: https://doi.org/10.1097/01.asn.0000077407.90309.65.
120.
JonesDRKeuneWJAndersonKE, et al.The hexosamine biosynthesis pathway and O-GlcNAcylation maintain insulin-stimulated PI3K-PKB phosphorylation and tumour cell growth after short-term glucose deprivation. FEBS J2014; 281: 3591–3608. DOI: https://doi.org/10.1111/febs.12879.
121.
LiCMiaoXLiF, et al.Oxidative stress-related mechanisms and antioxidant therapy in diabetic retinopathy. Oxid Med Cell Longev2017; 2017: 9702820. DOI: https://doi.org/10.1155/2017/9702820.
122.
Alfonso-MunozEABurggraaf-Sanchez de Las MatasRMataix BoronatJ, et al.Role of oral antioxidant supplementation in the current management of diabetic retinopathy. Int J Mol Sci2021; 22: 1–31. DOI: https://doi.org/10.3390/ijms22084020
123.
LiXWChenHPHeYY, et al.Effects of rich-polyphenols extract of dendrobium loddigesii on anti-diabetic, anti-inflammatory, anti-oxidant, and gut microbiota modulation in db/db mice. Molecules2018; 23: 1–20. DOI: https://doi.org/10.3390/molecules23123245
124.
ZarrinparAChaixAYoosephS, et al.Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab2014; 20: 1006–1017. DOI: https://doi.org/10.1016/j.cmet.2014.11.008.
125.
HicksALLeeKJCouto-RodriguezM, et al.Gut microbiomes of wild great apes fluctuate seasonally in response to diet. Nat Commun2018; 9: 1786. DOI: https://doi.org/10.1038/s41467-018-04204-w.
126.
CurovicVRSuvitaivalTMattilaI, et al.Circulating metabolites and lipids are associated to diabetic retinopathy in individuals with type 1 diabetes. Diabetes2020; 69: 2217–2226. DOI: https://doi.org/10.2337/db20-0104.
BarlowGMYuAMathurR. Role of the gut microbiome in obesity and diabetes mellitus. Nutr Clin Pract2015; 30: 787–797. DOI: https://doi.org/10.1177/0884533615609896.
129.
DevarajSHemarajataPVersalovicJ. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem2013; 59: 617–628. DOI: https://doi.org/10.1373/clinchem.2012.187617.
130.
GunardiTHSusantonoDPVictorAA, et al.Atopobiosis and dysbiosis in ocular diseases: is fecal microbiota transplant and probiotics a promising solution?J Ophthalmic Vis Res2021; 16: 631–643. DOI: https://doi.org/10.18502/jovr.v16i4.9754.
